GlassScriptPhysician profile
Hayley E Scholl
NPI 1457889727
$695.84
in general payments reported to CMS, 2019-2025
12 companies · $411 in 2025
The $411 reported for 2025 was more than what 76% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $285 · 2025: $411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $696.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $695.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $173.96 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $133.36 | 2024-2025 | Veozah |
| Mayne Pharma Commercial LLC | $80.94 | 2024-2025 | |
| Millicent US INC | $66.05 | 2024-2025 | Intrarosa, Femlyv |
| Evofem Biosciences, INC. | $63.11 | 2024-2025 | Phexxi, Solosec, Phexx |
| Exeltis, USA INC. | $41.25 | 2024-2025 | Slynd |
| Merck Sharp & Dohme LLC | $34.66 | 2024-2025 | Gardasil 9, Gardasil |
| Organon LLC | $30.68 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.65 | 2025 | |
| Smith+Nephew, INC. | $19.28 | 2025 | Pico 7, Pico 14 |
| Pfizer INC. | $17.98 | 2024 | |
| Meditrina | $9.92 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hayley Scholl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.